Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples